Tomas Fristedt

Title: Innovator Spotlight: Tomas Fristedt

Introduction

Tomas Fristedt, an accomplished inventor based in Helsingborg, Sweden, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio that includes six patents, Fristedt's work reflects his dedication to advancing medical science through innovative solutions.

Latest Patents

Among Tomas Fristedt's most notable patents is a pharmaceutical composition for stable laquinimod preparations. This invention includes N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, along with a pharmaceutically acceptable carrier, designed for efficient therapeutic use. Another significant patent involves crystalline salts of quinoline compounds and methods for preparing them. This stable solid pharmaceutical composition remains effective under storage conditions for long durations, highlighting Fristedt's emphasis on stability and efficacy in pharmaceutical formulations.

Career Highlights

Throughout his career, Tomas Fristedt has contributed to esteemed organizations, including Active Biotech AB and Teva Pharmaceutical Industries Limited. His work in these companies underlines his commitment to research and development in the pharmaceutical sector, exemplifying his focus on creating impactful health solutions.

Collaborations

Fristedt has collaborated with notable professionals such as Karl Erik Jansson and Muhammad Safadi. These partnerships have facilitated the sharing of knowledge and expertise, driving forward the innovative research that characterizes his patents and contributions to the field.

Conclusion

In summary, Tomas Fristedt is a pioneering inventor in the pharmaceutical industry, whose six patents illustrate his ongoing commitment to developing effective and stable drug formulations. His extensive work and collaborations underscore the profound impact he has made in advancing the field, inspiring future innovations in pharmaceuticals.